DK1506295T3 - Muteiner af placental vækstfaktor type 1, fremstillingsfremgangsmåde og anvendelser deraf - Google Patents

Muteiner af placental vækstfaktor type 1, fremstillingsfremgangsmåde og anvendelser deraf

Info

Publication number: DK1506295T3
Authority: DK; Denmark
Prior art keywords: preparation; growth factor; muteins; placental growth; applications
Prior art date: 2002-05-17

Application number

DK03727958.5T

Other languages

English (en)

Inventor

Mauro Battisti

Ettore Conti

Giuseppe Salvia

Marina Tucci

Alberto Mion

Domenico Maglione

Original Assignee

Geymonat Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-17

Filing date

2003-05-19

Publication date

2011-03-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11456311&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1506295(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-05-19 Application filed by Geymonat Spa filed Critical Geymonat Spa

2011-03-07 Application granted granted Critical

2011-03-07 Publication of DK1506295T3 publication Critical patent/DK1506295T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Immunology (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Cardiology (AREA)
Mycology (AREA)
Urology & Nephrology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK03727958.5T 2002-05-17 2003-05-19 Muteiner af placental vækstfaktor type 1, fremstillingsfremgangsmåde og anvendelser deraf DK1506295T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT2002RM000277A ITRM20020277A1 (it)	2002-05-17	2002-05-17	Muteine del fattore di crescita placentare tipo 1, metodo di preparazione e loro applicazioni.
PCT/IT2003/000296 WO2003097688A2 (en)	2002-05-17	2003-05-19	Muteins of placental growth factor type 1, preparation method and application thereof

Publications (1)

Publication Number	Publication Date
DK1506295T3 true DK1506295T3 (da)	2011-03-07

Family

ID=11456311

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03727958.5T DK1506295T3 (da)	2002-05-17	2003-05-19	Muteiner af placental vækstfaktor type 1, fremstillingsfremgangsmåde og anvendelser deraf

Country Status (22)

Country	Link
US (1)	US7314734B2 (da)
EP (1)	EP1506295B1 (da)
JP (1)	JP4230450B2 (da)
KR (1)	KR101022934B1 (da)
CN (1)	CN1323167C (da)
AT (1)	ATE488590T1 (da)
AU (1)	AU2003234066B2 (da)
BR (1)	BR0309966A (da)
CA (1)	CA2485587C (da)
CY (1)	CY1111431T1 (da)
DE (1)	DE60334986D1 (da)
DK (1)	DK1506295T3 (da)
ES (1)	ES2356360T3 (da)
HK (1)	HK1079549A1 (da)
HR (1)	HRP20041178B1 (da)
IT (1)	ITRM20020277A1 (da)
MX (1)	MXPA04011405A (da)
PL (1)	PL209955B1 (da)
PT (1)	PT1506295E (da)
RU (1)	RU2344172C2 (da)
WO (1)	WO2003097688A2 (da)
ZA (1)	ZA200409943B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2509063C (en)	2002-11-16	2010-11-02	Dade Behring Marburg Gmbh	Scd40l and placental growth factor (plgf) as biochemical marker combinations in cardiovascular diseases
DE102005022047A1 (de) *	2005-05-09	2006-11-30	Dade Behring Marburg Gmbh	Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
JP2009100680A (ja) *	2007-10-23	2009-05-14	Univ Nagoya	ヒト全身性強皮症動物モデルの作製方法、ヒト全身性強皮症動物モデル及びその用途
CN101918834B (zh)	2008-01-07	2014-05-28	奥索临床诊断有限公司	用于同时分析能够彼此络合的蛋白质的校准物/对照物
RU2010133157A (ru) *	2008-01-07	2012-02-20	Орто-Клиникал Дайэгностикс, Инк. (Us)	Определение комплекса sflt-1:ангиогенный фактор
EP2295449A1 (en) *	2009-09-09	2011-03-16	Dompe PHA.R.MA S.p.A.	PLGF-1 in homodimeric form
CN103087153B (zh) *	2011-10-28	2015-05-06	上海市第一人民医院	一类新的抑制新生血管的小肽及其应用
CA2913676A1 (en)	2013-05-31	2014-12-04	Cobiores Nv	Human plgf-2 for the prevention or treatment of heart failure
CN109134650A (zh) *	2018-09-10	2019-01-04	宁波奥丞生物科技有限公司	抗人plgf单克隆抗体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1242149B (it)	1990-09-27	1994-02-16	Consiglio Nazionale Ricerche	Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi
CA2064331C (en) *	1991-03-28	2003-02-18	Marvin L. Bayne	Vascular endothelial cell growth factor c subunit
SE9601245D0 (sv) *	1996-03-29	1996-03-29	Pharmacia Ab	Chimeric superantigens and their use
DE19748734A1 (de) *	1997-11-05	1999-05-06	Biotechnolog Forschung Gmbh	Verfahren zur Gewinnung von biologisch aktiven Dimeren von rekombinanten humanen Wachstumsfaktoren aus der Cystein-Knoten-Familie sowie Verwendung der gewonnenen Dimere
WO2000075163A1 (en) *	1999-06-03	2000-12-14	Human Genome Sciences, Inc.	Angiogenic proteins and uses thereof
WO2001085796A2 (en) *	2000-05-12	2001-11-15	Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw	Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage

2002
- 2002-05-17 IT IT2002RM000277A patent/ITRM20020277A1/it unknown
2003
- 2003-05-19 WO PCT/IT2003/000296 patent/WO2003097688A2/en active Application Filing
- 2003-05-19 AT AT03727958T patent/ATE488590T1/de active
- 2003-05-19 KR KR1020047018601A patent/KR101022934B1/ko not_active IP Right Cessation
- 2003-05-19 MX MXPA04011405A patent/MXPA04011405A/es active IP Right Grant
- 2003-05-19 AU AU2003234066A patent/AU2003234066B2/en not_active Ceased
- 2003-05-19 DK DK03727958.5T patent/DK1506295T3/da active
- 2003-05-19 DE DE60334986T patent/DE60334986D1/de not_active Expired - Lifetime
- 2003-05-19 ES ES03727958T patent/ES2356360T3/es not_active Expired - Lifetime
- 2003-05-19 CA CA2485587A patent/CA2485587C/en not_active Expired - Fee Related
- 2003-05-19 CN CNB038112043A patent/CN1323167C/zh not_active Expired - Fee Related
- 2003-05-19 JP JP2004506360A patent/JP4230450B2/ja not_active Expired - Fee Related
- 2003-05-19 BR BR0309966-0A patent/BR0309966A/pt not_active IP Right Cessation
- 2003-05-19 RU RU2004137000/13A patent/RU2344172C2/ru not_active IP Right Cessation
- 2003-05-19 US US10/514,707 patent/US7314734B2/en not_active Expired - Fee Related
- 2003-05-19 PT PT03727958T patent/PT1506295E/pt unknown
- 2003-05-19 PL PL372492A patent/PL209955B1/pl unknown
- 2003-05-19 EP EP03727958A patent/EP1506295B1/en not_active Expired - Lifetime
2004
- 2004-12-08 ZA ZA2004/09943A patent/ZA200409943B/en unknown
- 2004-12-10 HR HRP20041178AA patent/HRP20041178B1/hr not_active IP Right Cessation
2005
- 2005-12-19 HK HK05111674A patent/HK1079549A1/xx not_active IP Right Cessation
2011
- 2011-02-16 CY CY20111100200T patent/CY1111431T1/el unknown

Also Published As

Publication number	Publication date
PT1506295E (pt)	2011-02-23
PL209955B1 (pl)	2011-11-30
ITRM20020277A0 (it)	2002-05-17
EP1506295B1 (en)	2010-11-17
RU2344172C2 (ru)	2009-01-20
WO2003097688A2 (en)	2003-11-27
US7314734B2 (en)	2008-01-01
ITRM20020277A1 (it)	2003-11-17
KR20040111639A (ko)	2004-12-31
MXPA04011405A (es)	2005-02-14
EP1506295A2 (en)	2005-02-16
CY1111431T1 (el)	2015-08-05
CA2485587A1 (en)	2003-11-27
CA2485587C (en)	2012-08-21
HRP20041178B1 (hr)	2013-11-22
ZA200409943B (en)	2005-09-28
WO2003097688A3 (en)	2004-02-26
ES2356360T3 (es)	2011-04-07
JP2006508637A (ja)	2006-03-16
CN1323167C (zh)	2007-06-27
HRP20041178A2 (en)	2005-10-31
KR101022934B1 (ko)	2011-03-16
US20050176634A1 (en)	2005-08-11
CN1653177A (zh)	2005-08-10
WO2003097688A9 (en)	2005-01-06
ATE488590T1 (de)	2010-12-15
BR0309966A (pt)	2005-03-01
AU2003234066B2 (en)	2009-04-23
PL372492A1 (en)	2005-07-25
JP4230450B2 (ja)	2009-02-25
AU2003234066A1 (en)	2003-12-02
DE60334986D1 (de)	2010-12-30
HK1079549A1 (en)	2006-04-07
RU2004137000A (ru)	2005-06-10

Publication	Publication Date	Title
CY1111431T1 (el)	2015-08-05	Μεταλλαγμενες πρωτεϊνες πλακουντιου αυξητικου παραγοντα τυπου 1, μεθοδος παρασκευης και εφαρμογες αυτων
RU2009100884A (ru)	2010-07-20	Пептидные фрагменты для индукции синтеза белков внеклеточного матрикса
ATE417595T1 (de)	2009-01-15	Keratin-bindende polypeptide
FI860153A0 (fi)	1986-01-13	Oligopeptider, deras mellanprodukter och foerfarande foer deras framstaellning.
NO20071369L (no)	2007-05-04	Antimikrobiske peptider omfattende et arginin- og/eller lysin-inneholdende motiv
ATE169304T1 (de)	1998-08-15	Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung
HUP0004560A2 (hu)	2001-04-28	Törést gyógyító PTHrP analógok
DE602006020898D1 (de)	2011-05-05	Peptide zur förderung des haarwachstums und zur verbesserung von falten und kosmetische zusammensetzungen, die diese enthalten
DE602004001727D1 (de)	2006-09-14	Verfahren zur herstellung cyclischer peptide
NO331277B1 (no)	2011-11-14	Farmasoytisk sammensetning omfattende polypetid/nukleinsyre for behandling av retinale degenererende sykdommer, vektor, isolert polypeptid, renset antistoff og anvendelse av polypeptid, nukleinsyre og antistoff, samt fremgangsmater og kit
ATE211391T1 (de)	2002-01-15	Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
KR950032165A (ko)	1995-12-20	토코페롤 유도체
NO20010940L (no)	2001-04-23	TAN-1057 derivater
DE60322064D1 (de)	2008-08-21	4,4' -dithiobis- (3-aminobutane-1-sulfonate)-derivate und sie enthaltende zusammensetzungen
WO2002004487A3 (de)	2002-09-19	Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen
CY1105105T1 (el)	2009-11-04	Χρηση του διστροντιου αλατος του 2-[ν,ν-δι(καρβοξυμεξυλ) amino]- 3-κυανο-4-καρβοξυμεθυλ-θειοφενο-5-καρβοξυλικου οξεος για τη ληψη φαρμακων που προοριζονται για τη θεραπεια γαστρο-δωδεκαδακτυλικων πονων
KR950010884A (ko)	1995-05-15	사람 및 동물에서 염증성 반응을 일으키는 공격 또는 패혈증 치료용의 아미노산계 조성물
HRP20050787A2 (en)	2006-12-31	Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino) phenylacetic acid
KR940007059A (ko)	1994-04-26	변형된 혈소판 인자-4
DE69834929D1 (de)	2006-07-27	Verwendung eines organspezifischen ernährungmittels
ATE425174T1 (de)	2009-03-15	Colchicosidanaloge
DE60018937D1 (de)	2005-04-28	Somatostatin analoge und deren verwendung zur behandlung von krebs
RU2003124254A (ru)	2005-02-27	Косметическое средство для ухода за кожей лица и шеи
SE0202608D0 (sv)	2002-09-04	New sequences
DK0423326T3 (da)	1999-05-25	Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta